<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03412851</url>
  </required_header>
  <id_info>
    <org_study_id>CO-18-V1.0</org_study_id>
    <nct_id>NCT03412851</nct_id>
  </id_info>
  <brief_title>COmparing CeNters ThRombectomy Aspiration STentretriever</brief_title>
  <acronym>CONTRAST</acronym>
  <official_title>COmparing CeNters ThRombectomy Aspiration STentretriever</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospitales Universitarios Virgen del Rocío</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospitales Universitarios Virgen del Rocío</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aims is to evaluate the equality in efficacy and safety between direct aspiration
      technique and stent retriever thrombectomy procedure in anterior circulation strokes in a
      multicenter, prospective study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>modified rankin scale (mRs) at 90 days [effectiveness]</measure>
    <time_frame>90 days</time_frame>
    <description>Is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.
Score Description: The scale runs from 0-6, running from perfect health without symptoms to death.
0 No symptoms at all
No significant disability despite symptoms; able to carry out all usual duties and activities Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance Moderate disability; requiring some help, but able to walk without assistance Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance Severe disability; bedridden, incontinent and requiring constant nursing care and attention Dead [Time Frame: 90 days]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracranial bleeding [safety of the technique]</measure>
    <time_frame>during admission</time_frame>
    <description>The rate of patients with intracranial hemorrhage (measured by computed tomography) with worsening of 4 points on the NIHSS scale will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombolysis in cerebral infarction (TICI) scale 2b-3 [effectiveness]</measure>
    <time_frame>Up to 24 hours after endovascular reperfusion</time_frame>
    <description>After endovascular reperfusion technique, TICI score will be evaluated in all consecutive patients. The rate of TICI 2b-3 will be recorded as a effectiveness endpoint.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Stroke</condition>
  <arm_group>
    <arm_group_label>A Direct Aspiration First Pass Technique</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Stentriever Thrombectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A Direct Aspiration First Pass Technique</intervention_name>
    <description>Distal aspiration technique</description>
    <arm_group_label>A Direct Aspiration First Pass Technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stentriever Thrombectomy</intervention_name>
    <description>Thrombectomy with stent retriever</description>
    <arm_group_label>Stentriever Thrombectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ischemic stroke in which imaging demonstrates a vascular occlusion
        located in the distal internal carotid artery (ICA) through the distal middle cerebral
        artery (MCA).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject experiencing an acute ischemic stroke in which imaging demonstrates a vascular
             occlusion located in the distal internal carotid artery (ICA) through the distal
             middle cerebral artery (MCA).

          -  Subjects in which the aspiration technique is used for at least the first two
             thrombectomy passes per occluded vessel.

          -  Subjects older than 18 yo.

          -  Subjects with a prestroke modified Rankin scale of 0-2 and presenting with an NIHSS of
             2-30.

          -  Subjects that the operator feels may be treated with endovascular therapy

          -  Subjects in which computed tomography (CT)/Magnetic Resonance Imaging (MRI)
             demonstrates an infarct size of less than 70cc on MRI or Alberta Stroke Program Early
             CT (ASPECTS) score overall of 6 or better.

          -  Subjects in which groin puncture can be obtained within 6 hours of symptom onset (with
             or without Total Plasminogen Activator administration). In those Patients of more than
             8 hours or awake stroke or of unknown onset should be individualized the treatment and
             must exist area of penumbra in CT perfusion

          -  Subjects who have consented in accordance with local Institutional Review Board
             requirements

        Exclusion Criteria:

          -  Absence of large vessel occlusion on neuroimaging.

          -  Platelet count &lt; 100 x 10³ cells/mm³ or known platelet dysfunction.

          -  Contraindication to CT and/or MRI (i.e., due to contrast allergy or prior implant that
             precludes MRI imaging).

          -  Previously documented contrast allergy that is not amenable to medical treatment.

          -  Women who are pregnant or breastfeeding at time of intervention.

          -  Evidence of brain hemorrhage on CT and/or MRI at presenting hospital.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alejandro González, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospitales Universitarios Virgen del Rocío</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alejandro González, MD, PhD</last_name>
    <phone>+34 696646686</phone>
    <email>ggjandro@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Luna</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernando Delgado, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Pablo Alcazar, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Insular de Gran Canaria</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yeray Aguilar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Vega, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Donostia</name>
      <address>
        <city>San Sebastián</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Navia, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrés González Mandly, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Arenillas, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospitales Universitarios Virgen del Rocío</investigator_affiliation>
    <investigator_full_name>Alejandro González</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Thrombectomy</keyword>
  <keyword>Stentriever</keyword>
  <keyword>ADAPT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

